Rummakko; Petteri

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rummakko; Petteri.The latest application filed is for "pyran dervatives as cyp11a1 (cytochrome p450 monooxygenase 11a1) inhibitors".

Company Profile

3.12.16

Rummakko; Petteri - Siuntio FI
Rummakko; Petteri - Espoo FI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyran Dervatives As Cyp11a1 (cytochrome P450 Monooxygenase 11a1) Inhibitors App 20210347765 - DIN BELLE; David ; et al.	2021-11-11
Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors Grant 11,098,032 - Din Belle , et al. August 24, 2	2021-08-24
Pyran Dervatives As Cyp11a1 (cytochrome P450 Monooxygenase 11a1) Inhibitors App 20200299280 - DIN BELLE; David ; et al.	2020-09-24
Pyran dervatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors Grant 10,717,726 - Din Belle , et al.	2020-07-21
Pyran Dervatives As Cyp11a1 (cytochrome P450 Monooxygenase 11a1) Inhibitors App 20190359601 - DIN BELLE; David ; et al.	2019-11-28
CYP17 inhibitors/antiandrogens Grant 9,890,139 - Wohlfahrt , et al. February 13, 2	2018-02-13
Novel Cyp17 Inhibitors/antiandrogens App 20160130254 - WOHLFAHRT; Gerd ; et al.	2016-05-12
2,3-dihydrobenzo[1,4] dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases Grant 8,809,536 - Din Belle , et al. August 19, 2	2014-08-19
2,3-dihydrobenzo[1,4] Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous System Diseases App 20140179926 - DIN BELLE; David ; et al.	2014-06-26
2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases Grant 8,697,723 - Din Belle , et al. April 15, 2	2014-04-15
2,3-dihydrobenzo(1,4) Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous System Diseases App 20130281486 - DIN BELLE; David ; et al.	2013-10-24
2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous systeme diseases Grant 8,492,549 - Din Belle , et al. July 23, 2	2013-07-23
2,3-dihydrobenzo(1,4) Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous Systeme Diseases App 20120035210 - Din Belle; David ; et al.	2012-02-09
Crystallization process of quetiapine hemifumarate Grant 8,044,038 - Rummakko , et al. October 25, 2	2011-10-25
Quetiapine hemifumarate purification by crystallization Grant 8,044,039 - Grumann , et al. October 25, 2	2011-10-25
Preparation of quetiapine Grant 7,863,441 - Rummakko , et al. January 4, 2	2011-01-04
Preparation method for quetiapine Grant 7,858,777 - Hilden , et al. December 28, 2	2010-12-28
2,3-dihydrobenzo(1,4) Dioxin-2-ylmethyl Derivatives As Alpha2c Antagonists For Use In The Treatment Of Peripheric And Central Nervous Systeme Diseases App 20100216836 - Din Belle; David ; et al.	2010-08-26
Quetiapine Hemifumarate Purification by Crystallization App 20090156802 - Grumann; Arme ; et al.	2009-06-18
Crystallization Process of Quetiapine Hemifumarate App 20090118497 - Rummakko; Petteri ; et al.	2009-05-07
Process For Preparing A Compound App 20090082597 - Grumann; Arne ; et al.	2009-03-26
Preparation of quetiapine App 20070111987 - Rummakko; Petteri ; et al.	2007-05-17
Preparation method for quetiapine App 20070111986 - Hilden; Leif ; et al.	2007-05-17
Process for the preparation of 1 - (3-dimethylaminopropyl) -1 - (4-fluorophenyl) -1,3-dihydroisobenzofuran-5-carbonitrile App 20050209467 - Hilden, Leif ; et al.	2005-09-22
Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-ca rbonitrile Grant 6,753,433 - Hilden , et al. June 22, 2	2004-06-22
Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl- )-1,3-dihydroisobenzofuran-5-carbonitrile App 20030130527 - Hilden, Leif ; et al.	2003-07-10
Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-Fluorophenyl- )-1,3-dihydroisobenzofuran-5-carbonitrile App 20020115872 - Hilden, Leif ; et al.	2002-08-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.